Previous research has reported positive associations between anger, perceived stress and blood pressure. These associations have largely been based on cross-sectional data and a small number of longitudinal works. Using a prospective longitudinal cohort design, this study more directly tested the relationships between anger, perceived stress and blood pressure by using a psychological therapeutic intervention (mindfulness-based stress reduction) to manipulate anger and perceived stress. Anger and perceived stress were in turn evaluated for association with blood pressure. Despite improvements in psychosocial functioning and reductions in blood pressure, findings from this study failed to demonstrate an association between change in anger or perceived stress with change in daytime or 24-hour ambulatory blood pressure. A model where these variables interact indirectly via stress coping mechanisms or health behaviours may be the linking mechanism in this study. Results from this thesis have contributed evidence to a divided field dominated by cross-sectional research.

Objetivo: Investigar o efeito de se distinguir a pressão arterial noturna da pressão arterial no sono pelo registro simultâneo da monitorização ambulatorial da pressão arterial e da polissonografia. Métodos: Recrutaram-se 36 pacientes, 29 homens e 7 mulheres, com suspeita de síndrome das apnéias e hipopnéias obstrutivas do sono (SAHOS), encaminhados à clínica do sono para investigação diagnóstica e que concordaram usar o monitor ambulatorial de pressão arterial (MAPA) Spacelabs 90207 ABP durante a polissonografia (PSG). A média de idade dos indivíduos era 45 ± 11 anos; o índice de massa corporal (IMC), 30,8 ± 5,4 Kg/m2; o índice de apnéias e hipopnéias, 35 ± 29 AH/h. Um microfone acoplado ao monitor ambulatorial de PA registrou os sons característicos de sua atividade em um canal da polissonografia e permitiu determinar, de modo eletrográfico, se a PA foi medida em sono (e-sono) ou vigília (e-vigília).Resultados: Os pacientes encontravam-se dormindo durante (média+DP) 61+24% (variando de 0 a 100%), das 14+1 medidas de pressão arterial durante a noite. Leituras de pressão sistólica e diastólica na MAPA foram significativamente maiores durante o evigília (121 + 12 / 73 + 9 mm Hg) que durante o total do período noturno (119 + 11 / 70 + 8 mmHg) e e-sono (116 + 13 / 68 + 9 mm Hg). Baseado nas medidas do período noturno, 22 pacientes (61%) tinham hipertensão noturna; baseado nas medidas do período de e-sono, 12 pacientes tinham hipertensão noturna (33%; qui-quadrado= 5,54; p= 0,018). Um modelo de regressão linear múltipla mostrou que a percentagem de medidas feitas durante o e-sono foi a única variável que explicou significantemente a diferença entre os valores de PA noturna e PA em e-sono, controlando para gênero, idade, IMC, IAH, e SaO2 mínima. Conclusão: Durante a MAPA as leituras de PA noturnas são mais altas que as leituras durante e-sono. / Objective: Investigate the effect of distinguishing nighttime and sleep on nocturnal blood pressure results in ambulatory blood pressure monitoring (ABPM). Methods: We recruited 36 patients, 28 male, with suspected OSAHS attending a sleep clinic for diagnostic polysomnography (PSG) and who agreed to wear a Spacelabs 90207 ABP monitor during PSG. Their mean age was 45±11 years; body mass index (BMI), 30.8±5.4 kg/m2; apnea-hypopnea index (AHI), 35±29 AH/h; 13 had history of hypertension. A microphone attached to the ABP monitor recorded its sounds in the polygraph and allowed to classify each ABPM measurement as being made in electrographically-determined wake (e-wake) or sleep state (e-sleep). Results: Patients were asleep during (mean±SD) 61±24% (range 0 to 100%) of the 14±1 nighttime BP measurements. Systolic and diastolic ABPM readings were significantly higher during e-wake (121±12 / 73±9 mm Hg) than during total nighttime (119±11/70±8 m Hg) and e-sleep (116±13 / 68±9 mm Hg). Based on nighttime measurements 22 patients (61%) had nocturnal hypertension. Based on measurements made during e-sleep, nocturnal hypertension was diagnosed in 12 patients (33%; chisquare= 5.54; p= 0.018). A multiple linear regression model showed that the percentage of measurements made in e-sleep was the only variable that significantly explained the difference between nighttime and e-sleep BP figures, when controlling for gender, age, BMI, AHI, and lowest SaO2. Conclusion: During ABPM, nighttime BP readings are higher than during e-sleep and this changes dipping and nocturnal hypertension classification.

A taxa de controle da hipertensão arterial permanece subótima apesar dos amplos e intensos programas institucionais e o número das novas medicações. A combinação de drogas de diferentes mecanismos de ação vem se tornando uma alternativa para aumentar a redução na pressão arterial (PA) e aumentar seu controle, aumentar aderência ao tratamento e reduzir os eventos adversos. Um estudo fatorial 4X4 foi desenhado para determinar a eficácia e a segurança de telmisartana (T) mais anlodipino (A) em pacientes hipertensos estágios I e II. Pacientes hipertensos adultos (N=1461) estágios I e II (pressão arterial basal 153,212,1 &#8260;101,74,3 mm Hg) foram randomizados para 1 de 16 grupos de tratamento com T 0, 20, 40, 80 mg e A 0, 2.5, 5, 10 mg por oito semanas. A maior redução na média das pressões sistólica e diastólica foram observadas com T 80 mg mais A10 mg (- 26,4 &#8260;20,1 mm Hg; p<0,05 comparados com as monoterapias). A taxa de controle da PA foi também maior no grupo T 80mg mais A 10mg (76,5% [controle total] e 85,3% [controle da PA diastólica ]), e taxa de controle da PA >90% com esta combinação. O edema periférico maleolar foi o evento adverso mais frequente e ocorreu no grupo A 10mg (17,8%), porém, esta taxa foi marcadamente menor quando A foi usada associada com T: 11,4% (T20+A10), 6,2% (T40+ A10), e 11,3% (T80+A10). Um subestudo utilizando a monitorização ambulatorial da pressão arterial (MAPA) foi realizado na fase basal e após oito semanas de tratamento. A maior redução média das pressões nas 24 horas a partir do período basal foi registrada para a combinação de telmisartana 80 mg e anlodipino 10 mg e encontrou-se queda de 22,4/14,6 mmHg, de 11,9/6,9 mmHg para anlodipino 10 mg monoterapia e de 11,0/6,9 mmHg para telmisartana 80 mg (p< 0,001). Além disso, resultados relevantes foram também constatados numa análise post hoc de subgrupos incluindo idosos, obesos, diabéticos tipo 2 e hipertensão sistólica. A resposta anti-hipertensiva da combinação foi semelhante, independente de qualquer característica de cada subgrupo. Estes dados demonstram que telmisartana e anlodipino em combinação oferecem substancial redução e controle nas 24 horas superior às respectivas monoterapias em hipertensos estágios I e II. / The rate of control of hypertension remains suboptimal despite widespread educational programs and the increasing number of novel medications. The combination of drugs with different mechanism of action has become an alternative to improve blood pressure reduction and control, enhance adherence to the treatment and reduce adverse events. This randomized 4X4 factorial study determined the efficacy and safety of telmisartan (T) plus amlodipine (A) in hypertensive patients. Adults (N=1461) with stage 1 or 2 hypertension (baseline blood pressure (BP) 153.212.1 &#8260;101.74.3 mm Hg) were randomized to 1 of 16 treatment groups with T 0, 20, 40, 80 mg and A 0, 2.5, 5, 10 mg for 8 weeks. The greatest leastsquare mean systolic &#8260; diastolic BP reductions were observed with T80 mg plus A10 mg (- 26.4 &#8260;20.1 mm Hg; P<.05 compared with both monotherapies). BP control was also greater in the T80-mg plus A10-mg group (76.5% [overall control] and 85.3% [diastolic BP control]), and BP response rates >90% with this combination. Peripheral edema was most common in the A10-mg group (17.8%); however, this rate was notably lower when A was used in combination with T: 11.4% (T20 &#8260; A10), 6.2% (T40 &#8260; A10), and 11.3% (T80 &#8260; A10). Ambulatory BP monitoring (ABPM) was performed, at baseline and after 8 weeks of treatment; the endpoints of interest were the changes from baseline in 24-hour systolic and diastolic BP. Mean reductions from baseline in 24-hour BP for the combination of the highest doses of telmisartan 80 mg and amlodipine 10 mg were -22.4/-14.6 mmHg versus -11.9/-6.9 mmHg for amlodipine 10 mg and -11.0/-6.9 mmHg for telmisartan 80 mg (p< 0.001 for each comparison. This study also presents most of the relevant results in hypertensive patients and a post hoc analysis of subgroups including elderly, diabetics type 2, systolic hypertension and obese patients. These findings demonstrate that telmisartan and amlodipine in combination provide substantial 24 hour BP efficacy that is superior to either monotherapy in patients with stages 1 and 2 hypertension.

Objetivo: Investigar o efeito de se distinguir a pressão arterial noturna da pressão arterial no sono pelo registro simultâneo da monitorização ambulatorial da pressão arterial e da polissonografia. Métodos: Recrutaram-se 36 pacientes, 29 homens e 7 mulheres, com suspeita de síndrome das apnéias e hipopnéias obstrutivas do sono (SAHOS), encaminhados à clínica do sono para investigação diagnóstica e que concordaram usar o monitor ambulatorial de pressão arterial (MAPA) Spacelabs 90207 ABP durante a polissonografia (PSG). A média de idade dos indivíduos era 45 ± 11 anos; o índice de massa corporal (IMC), 30,8 ± 5,4 Kg/m2; o índice de apnéias e hipopnéias, 35 ± 29 AH/h. Um microfone acoplado ao monitor ambulatorial de PA registrou os sons característicos de sua atividade em um canal da polissonografia e permitiu determinar, de modo eletrográfico, se a PA foi medida em sono (e-sono) ou vigília (e-vigília).Resultados: Os pacientes encontravam-se dormindo durante (média+DP) 61+24% (variando de 0 a 100%), das 14+1 medidas de pressão arterial durante a noite. Leituras de pressão sistólica e diastólica na MAPA foram significativamente maiores durante o evigília (121 + 12 / 73 + 9 mm Hg) que durante o total do período noturno (119 + 11 / 70 + 8 mmHg) e e-sono (116 + 13 / 68 + 9 mm Hg). Baseado nas medidas do período noturno, 22 pacientes (61%) tinham hipertensão noturna; baseado nas medidas do período de e-sono, 12 pacientes tinham hipertensão noturna (33%; qui-quadrado= 5,54; p= 0,018). Um modelo de regressão linear múltipla mostrou que a percentagem de medidas feitas durante o e-sono foi a única variável que explicou significantemente a diferença entre os valores de PA noturna e PA em e-sono, controlando para gênero, idade, IMC, IAH, e SaO2 mínima. Conclusão: Durante a MAPA as leituras de PA noturnas são mais altas que as leituras durante e-sono. / Objective: Investigate the effect of distinguishing nighttime and sleep on nocturnal blood pressure results in ambulatory blood pressure monitoring (ABPM). Methods: We recruited 36 patients, 28 male, with suspected OSAHS attending a sleep clinic for diagnostic polysomnography (PSG) and who agreed to wear a Spacelabs 90207 ABP monitor during PSG. Their mean age was 45±11 years; body mass index (BMI), 30.8±5.4 kg/m2; apnea-hypopnea index (AHI), 35±29 AH/h; 13 had history of hypertension. A microphone attached to the ABP monitor recorded its sounds in the polygraph and allowed to classify each ABPM measurement as being made in electrographically-determined wake (e-wake) or sleep state (e-sleep). Results: Patients were asleep during (mean±SD) 61±24% (range 0 to 100%) of the 14±1 nighttime BP measurements. Systolic and diastolic ABPM readings were significantly higher during e-wake (121±12 / 73±9 mm Hg) than during total nighttime (119±11/70±8 m Hg) and e-sleep (116±13 / 68±9 mm Hg). Based on nighttime measurements 22 patients (61%) had nocturnal hypertension. Based on measurements made during e-sleep, nocturnal hypertension was diagnosed in 12 patients (33%; chisquare= 5.54; p= 0.018). A multiple linear regression model showed that the percentage of measurements made in e-sleep was the only variable that significantly explained the difference between nighttime and e-sleep BP figures, when controlling for gender, age, BMI, AHI, and lowest SaO2. Conclusion: During ABPM, nighttime BP readings are higher than during e-sleep and this changes dipping and nocturnal hypertension classification.

Objetivo: Investigar o efeito de se distinguir a pressão arterial noturna da pressão arterial no sono pelo registro simultâneo da monitorização ambulatorial da pressão arterial e da polissonografia. Métodos: Recrutaram-se 36 pacientes, 29 homens e 7 mulheres, com suspeita de síndrome das apnéias e hipopnéias obstrutivas do sono (SAHOS), encaminhados à clínica do sono para investigação diagnóstica e que concordaram usar o monitor ambulatorial de pressão arterial (MAPA) Spacelabs 90207 ABP durante a polissonografia (PSG). A média de idade dos indivíduos era 45 ± 11 anos; o índice de massa corporal (IMC), 30,8 ± 5,4 Kg/m2; o índice de apnéias e hipopnéias, 35 ± 29 AH/h. Um microfone acoplado ao monitor ambulatorial de PA registrou os sons característicos de sua atividade em um canal da polissonografia e permitiu determinar, de modo eletrográfico, se a PA foi medida em sono (e-sono) ou vigília (e-vigília).Resultados: Os pacientes encontravam-se dormindo durante (média+DP) 61+24% (variando de 0 a 100%), das 14+1 medidas de pressão arterial durante a noite. Leituras de pressão sistólica e diastólica na MAPA foram significativamente maiores durante o evigília (121 + 12 / 73 + 9 mm Hg) que durante o total do período noturno (119 + 11 / 70 + 8 mmHg) e e-sono (116 + 13 / 68 + 9 mm Hg). Baseado nas medidas do período noturno, 22 pacientes (61%) tinham hipertensão noturna; baseado nas medidas do período de e-sono, 12 pacientes tinham hipertensão noturna (33%; qui-quadrado= 5,54; p= 0,018). Um modelo de regressão linear múltipla mostrou que a percentagem de medidas feitas durante o e-sono foi a única variável que explicou significantemente a diferença entre os valores de PA noturna e PA em e-sono, controlando para gênero, idade, IMC, IAH, e SaO2 mínima. Conclusão: Durante a MAPA as leituras de PA noturnas são mais altas que as leituras durante e-sono. / Objective: Investigate the effect of distinguishing nighttime and sleep on nocturnal blood pressure results in ambulatory blood pressure monitoring (ABPM). Methods: We recruited 36 patients, 28 male, with suspected OSAHS attending a sleep clinic for diagnostic polysomnography (PSG) and who agreed to wear a Spacelabs 90207 ABP monitor during PSG. Their mean age was 45±11 years; body mass index (BMI), 30.8±5.4 kg/m2; apnea-hypopnea index (AHI), 35±29 AH/h; 13 had history of hypertension. A microphone attached to the ABP monitor recorded its sounds in the polygraph and allowed to classify each ABPM measurement as being made in electrographically-determined wake (e-wake) or sleep state (e-sleep). Results: Patients were asleep during (mean±SD) 61±24% (range 0 to 100%) of the 14±1 nighttime BP measurements. Systolic and diastolic ABPM readings were significantly higher during e-wake (121±12 / 73±9 mm Hg) than during total nighttime (119±11/70±8 m Hg) and e-sleep (116±13 / 68±9 mm Hg). Based on nighttime measurements 22 patients (61%) had nocturnal hypertension. Based on measurements made during e-sleep, nocturnal hypertension was diagnosed in 12 patients (33%; chisquare= 5.54; p= 0.018). A multiple linear regression model showed that the percentage of measurements made in e-sleep was the only variable that significantly explained the difference between nighttime and e-sleep BP figures, when controlling for gender, age, BMI, AHI, and lowest SaO2. Conclusion: During ABPM, nighttime BP readings are higher than during e-sleep and this changes dipping and nocturnal hypertension classification.

Indiana University-Purdue University Indianapolis (IUPUI) / Background: Ambulatory blood pressure (BP) monitoring (ABPM) remains a reference standard but the number of readings required to make the measurement valid has not been empirically validated. Methods: Among 360 patients with chronic kidney disease and 38 healthy controls, BP was recorded 2 per hour during the night and 3 per hour during the day over 24h using a validated ABPM device; all had at least 90% of the expected readings. From this full set of ABPM recording, a variable number of BP measurements were selected and we compared the performance of the selected readings against that of the full sample using random or sequential selection schemes. To address the question whether random or sequential selection schemes affect the diagnostic performance in diagnosing hypertension control we compared the diagnostic decisions reached with the subsample and the full sample using area under the receiver operating-characteristic curves (AUC ROC). To answer the question regarding the number of readings needed to achieve over 90% coverage of the mean BP of the full ABPM sample we ascertained the point and confidence interval (CI) estimates based on the selected data. Results: To diagnose hypertension control, the number of readings randomly drawn to establish lower bound with 2.5% error of area under the receiver operating-characteristic curve (AUC ROC) of 0.9 was 3, 0.95 was 7, and 0.975 was 13 . In contrast, the corresponding number of readings with serial selections was 18, 30 and 39 respectively. With a random selection scheme, 18 readings provided 80% coverage of the 90th percentile of CI of the true systolic BP mean, for 90% coverage, 26 readings were needed, for 95% coverage 33. With serial selections, the number of readings increased to 42, 47, and 50 respectively. Similar results emerged for diastolic BP. Conclusions: For diagnosing hypertension control 3 random measurements or 18 serial measurements is sufficient. For quantitative analysis, the minimal sufficient number of 24h ambulatory BP is 26 random recordings or 42 serial recordings.

Thesis (MMed (Obstetrics and Gynaecology))--University of Stellenbosch, 2010. / ENGLISH ABSTRACT: OBJECTIVE: The aim of this study was to compare the accuracy of non-invasive blood pressure measurements, using automated and manual devices, against invasive intra-arterial blood pressure measurements in patients with pre-eclampsia, during a hypertensive blood pressure peak. STUDY DESIGN: In this prospective study, women admitted to the Obstetrics Critical Care Unit, with confirmed pre-eclampsia and acute severe hypertension, who had an intra-arterial line in situ, were asked to participate. During an intra-arterial blood pressure peak, both an automated oscillometric and a blinded manual aneroid sphygmomanometric blood pressure was recorded. These two methods of blood pressure measurements were compared to intra-arterial blood pressure measurements. The accuracy of a mean arterial pressure (MAP) ≥ 125mmHg in detecting a systolic blood pressure (SBP) ≥ 160mmHg, using all three methods, was also determined. RESULTS: There was poor correlation between intra-arterial SBP and automated and manual SBP (r = 0.34, p < 0.01; r = 0.41, p < 0.01 respectively). The mean differences between automated and manual SBP compared to the intra-arterial SBP was 24 ± 17mmHg (p < 0.01) and 20 ± 15 mmHg (p < 0.01) respectively. There was better correlation between intra-arterial diastolic blood pressure (DBP) and automated and manual DBP (r = 0.61, p < 0.01; r = 0.59, p < 0.01 respectively). The mean differences of the automated and manual DBP was not statistically significant when compared to the intra-arterial DBP. There was poor correlation between the intra-arterial MAP and the automated MAP (r = 0.44, p < 0.01) and good correlation with the manual MAP (r = 0.56, p < 0.01). The mean differences of the automated and manual MAP were statistically significant (5 ± 13mmHg, p < 0.01; 8 ± 11mmHg, p < 0.01 respectively). The sensitivity of automated and manual methods in detecting a SBP ≥ 160mmHg was 23.4% and 37.5% respectively. A MAP ≥ 125mmHg in detecting a SBP ≥ 160mmHg, when using intra-arterial, automated and manual methods of blood pressure measurements showed low sensitivity (35.9%, 21.9% and 17.2% respectively). CONCLUSION: This study demonstrated that both the automated and manual methods of blood pressure measurements were not an accurate measure of the true systolic intra-arterial blood pressure, when managing pre-eclamptic patients with acute severe hypertension. In such situations, intra-arterial blood pressure monitoring should be used when possible. When this is not possible, manual aneroid sphygmomanometry is recommended. Underestimating blood pressure, particularly SBP, may lead to severe maternal morbidity and mortality. / AFRIKAANSE OPSOMMING: DOELWIT: Die doel van hierdie studie is om die akuraatheid van nie invasiewe bloeddruk metings, wanneer geneem met outomatiese en manuele aparate, te vergelyk met intra-arteriele bloed druk metings in pasiente met pre-eklampsie, gedurende ‘n hipertensiewe bloeddruk piek. STUDIE ONTWERP: In hierdie prospektiewe beskrywende dwarssnit studie, was pasiente wat toegelaat was tot die Obstetriese Kritieke Sorg Eenheid met pre-eklampsie, akute erge hipertensie en ‘n intra-arteriele lyn in situ gevra om deel te neem. Gedurende ‘n intra-arteriele erge hipertensiewe piek is beide die outomatiese ossilometriese en die geblinde aneroide sfigmometer lesing neergeskryf. Hierdie twee metodes van non invasiewe bloed druk lesings is vergelyk met intra-arteriele bloed druk lesings. Die akuraatheid van ‘n gemiddelde arteriele bloeddruk ≥ 125mmHg om ‘n sistoliese bloeddruk ≥ 160mmHg op te tel met gebruik van al die drie metodes is ook uitgewerk. RESULTATE: Daar was swak korrelasie tussen intra-arteriele sistoliese bloed druk (SBD) metings en outomatiese en manuele SBD (r = 0.34, p < 0.01; r = 0.41, p < 0.01 onderskeidelik). Die gemiddelde verskille tussen outomatiese en manuele SBD wanneer vergelyk met intra-arteriele SBD was 24 ± 17mmHg (p < 0.01) en 20 ± 15 mmHg (p < 0.01) onderskeidelik. Beter korrelasie was gevind tussen intra-arteriele diastoliese bloed druk (DBD) en outomatiese en manuele DBD (r = 0.61, p < 0.01; r = 0.59, p < 0.01 onderskeidelik). Die gemiddelde verskille tussen outomatiese en manuele DBD wanneer dit vergelyk was met intra-arteriele DBD was nie statisties betekenisvol nie. Daar was swak korrelasie tussen intra arteriele gemiddelde arteriele bloeddruk en outomatiese gemiddelde arteriele bloeddruk (r = 0.44, p < 0.01) en beter korrelasie met manuele gemiddelde arteriele bloeddruk (r = 0.56, p < 0.01). Die gemiddelde verskille van outomatiese en manuele gemiddelde arteriele bloeddruk was betekenisvol (5 ± 13mmHg, p < 0.01; 8 ± 11mmHg, p < 0.01 onderskeidelik). Die sensitiwiteit van outomatiese en manuele metodes om ‘n intra-arteriele SBD ≥ 160mmHg op te tel was 23.4% en 37.5% onderskeidelik. Die vermoë van ‘n gemiddelde arteriele bloeddruk ≥ 125mmHg om ‘n SBD ≥ 160mmHg op te tel, gemeet deur intra-arterieel, outomatiese en manuele metodes het lae sensitiwiteit getoon (35.9%, 21.9% en 17.2% onderskeidelik). GEVOLGTREKKING: Hierdie studie het gedemonstreer dat outomatiese en manuele metodes van bloeddruk meting nie akurate metodes is om ware intra-arteriele sistoliese bloeddruk te meet in pasiente met erge pre-eklampsie tydens ‘n erge hipertensiewe episode nie. In hierdie omstandighede moet intra-arteriele bloeddruk gemeet word indien beskikbaar. Indien dit nie beskikbaar is nie moet die manuele aneroiede sfigmomanometer gebruik word. Onderskatting van bloeddruk, veral sistoliese bloeddruk, kan lei tot erge moederlike morbiditeit en mortaliteit.

INTRODUÇÃO: Não são conhecidos os mecanismos que determinam o comportamento da pressão arterial durante o sono. OBJETIVO: Investigar o papel do sistema nervoso simpático, do sistema renina-angiotensinaaldosterona e da excreção de sódio urinário no descenso da pressão arterial durante o sono. MÉTODOS: Hipertensos e normotensos foram submetidos a duas monitorizações ambulatoriais de pressão arterial (MAPA)/24h com SpaceLabs 90207, medidas de 15/15 minutos durante a vigília e de 20/20 minutos no período de sono. Na ocasião da MAPA 1 foram submetidos às dosagens laboratoriais de atividade de renina (ARP), aldosterona e catecolaminas plasmáticas e excreção em diurese de 24h de sódio (Na+u), potássio (K+u) e creatinina. Após o período médio de 50 ± 20 (média ± DP) dias a MAPA e as dosagens foram repetidas. RESULTADOS: Foram incluídos 35 hipertensos e 24 normotensos, com idade 56 ± 12 anos, 45 mulheres e 42 com cor da pele branca. Não houve diferença nos parâmetros laboratoriais na ocasião da MAPA 1 e da MAPA 2 nos normotensos e hipertensos. Mantiveram o mesmo comportamento de descenso da pressão sistólica e diastólica durante o sono nas duas MAPAs (>= 10% ou < 10%) 29 (49%) indivíduos, denominado grupo manteve (hipertensos n = 18). Mudaram o comportamento do descenso durante o sono da pressão sistólica ou diastólica (de >= 10% para < 10% ou de < 10% para >= 10%) 30 (51%) indivíduos, denominado grupo mudou (hipertensos n = 17). O grupo \"mudou\" apresentou menor Na+u na ocasião da MAPA 2 (145 ± 65 mEq/24 h vs 120 ± 46 mEq/24 h, p = 0,04). Houve correlação positiva entre: a) a diferença do descenso da pressão sistólica e a diferença dos resultados das dosagens de Na+u (r = 0,41; p = 0,01) realizadas nas MAPAs 1 e 2 em todos os indivíduos dos grupos \"manteve\" e \"mudou\"; b) a diferença do descenso da pressão sistólica e a diferença de Na+u/creatinina urinária (r = 0,67; p = 0,03) e de L dopa plasmática (r = 0,75; p = 0,003) realizadas nas MAPAs 1 e 2 no grupo \"manteve\" (>= 10%); e c) a diferença do descenso da pressão sistólica e a diferença do resultado das dosagens de ARP/Na+u realizadas nas MAPAs 1 e 2 (r = 0,81; p = 0,03) no grupo \"manteve\" (< 10%). CONCLUSÃO: Em hipertensos e normotensos, sem intervenção medicamentosa ou dietética, a diferença do descenso da pressão sistólica durante o sono entre duas MAPAs apresenta correlação positiva com a diferença da excreção de sódio urinário / INTRODUCTION: The mechanisms which determine the pattern of blood pressure during sleep are unknown. OBJECTIVE: To investigate the role of the sympathetic nervous system, renin-angiotensin-aldosterone system and urinary sodium excretion in the nocturnal blood pressure fall. METHODS: Hypertensive and normotensive subjects were submitted to two ambulatorial blood pressure monitorings (ABPM)/24h with a SpaceLabs 90207 equipment programmed to obtain measurements 15/15 minutes while awake and 20/20 minutes during sleep. Upon the ABPM 1, they were submitted to laboratory measurements of plasma renin activity (PRA), plasma aldosterone and catecholamines, as well as of the excretion of sodium (UNa+), potassium (UK+) and creatinine in 24-h-diuresis. After a mean period of 50 ± 20 days, the ABPM and the laboratory measurements were repeated. RESULTS: Included in the study were 35 hypertensive and 24 normotensive subjects, aged 56 ± 12 years, of which 45 were females and 42 Caucasian. There was no difference in the laboratory parameters measured upon ABPM 1 or 2, in either normotensive or hypertensive subjects. The same pattern of nocturnal systolic and diastolic pressure fall was maintained in both ABPMs (>=10% or <10%) by 29 (49%) subjects, named the \"maintained\" group (hypertensive n = 18). The nocturnal systolic or diastolic pressure fall changed (from >=10% to <10% or from <10% to >=10%) in 30 (51%) subjects, named the \"changed\" group (hypertensive n = 17). The \"changed\" group showed a smaller UNa+ upon the ABPM 2 (145 ± 65 mEq/24 h vs 120 ± 46 mEq/24 h; p = 0.04). There was a positive correlation between the difference in the nocturnal systolic pressure fall and the difference in the results of the UNa+ (r = 0,41; p = 0,01) measurements performed upon ABPM 1 and 2 in the normotensive or hypertensive subjects of the \"maintained\" and \"changed\" groups; b) the difference in the nocturnal systolic pressure fall and the difference in the measurements of UNa+/creatinine excretion (r = 0.67; p = 0.025) and plasma L dopa (r = 0.75; p = 0.003) carried out upon ABPM 1 and 2 in the \"maintained\" group (>=10%); and c) the difference in the nocturnal systolic pressure fall and the difference in the results of the PRA/UNa+ measurements performed upon ABPM 1 and 2 (r = 0.81; p = 0.03) in the \"maintained\" group (<10%). CONCLUSION: In hypertensive and normotensive individuals, without any pharmacological or dietary intervention, the difference in the nocturnal systolic pressure fall between the two ABPMs shows a positive correlation with the difference in urinary sodium excretion

O pré-diabetes (PDM), da mesma forma que o diabetes mellitus (DM), associa-se com complicações micro e macrovasculares. Existem evidências de que existem anormalidades da homestoase da pressão arterial em indivíduos com PDM. Através da monitorização ambulatorial da pressão arterial (MAPA) é possível identificar o padrão de homeostase pressórica de indivíduos com diferentes graus de tolerância à glicose. Evidências demonstram que as medidas de pressão arterial (PA) obtidas por MAPA apresentam melhor associação com lesões de órgãos alvo se comparadas a medidas obtidas em consultório. Medidas de PA obtidas através de MAPA demonstram melhor correlação com complicações crônicas microvasculares do DM. Entretanto, dispõe-se de poucos dados na literatura sobre o comportamento da pressão arterial de 24 horas em indivíduos com PDM. Este trabalho é inicialmente constituído de uma revisão direcionada sobre homeostase pressórica em indivíduos com diferentes graus de tolerância à glicose seguido de um artigo original a respeito do tema. O artigo se trata de um estudo transversal que avaliou o padrão de homeostase pressórica de 24 horas em 138 indivíduos com diferentes graus de tolerância à glicose. O estudo demonstrou que através da MAPA é possível observar uma elevação dos níveis de pressão arterial ao longo de 24 horas de acordo com a piora da tolerância à glicose. / As diabetes mellitus (DM), prediabetes is associated with microvascular and macrovascular complications. There is evidence of presence of abnormalities in blood pressure (BP) homeostasis in individuals with prediabetes (PDM). Ambulatory blood pressure monitoring (ABPM) enables to identify the pattern of BP homeostasis in individuals with different degrees of glucose tolerance. Evidences have shown that BP measurements obtained by ABPM have a better association with target organ damage compared to measurements obtained in the office. Studies have also shown better correlation of BP measurements obtained by ABPM with microvascular chronic complications of DM. However, there are few data in literature about the behavior of 24 hours BP in subjects with prediabetes. This study consists of a review focused on BP homeostasis in subjects with different degrees of glucose tolerance and an original article about this issue. This is a cross-sectional study that evaluated how BP homeostasis behaves along 24 hours in 138 subjects with different degrees of glucose tolerance. The study demonstrated that through the ABPM is possible to observe an increase in blood pressure levels over 24 hours according to a worsening of glucose tolerance.

Chan, Chun Hung. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references (leaves 77-84). / Abstracts in Chinese and English. / Acknowledgment: --- p.i / 摘要 --- p.ii / Abstract --- p.iv / List of Figure --- p.vi / List of Table --- p.viii / Content Page --- p.ix / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- The Difficulties --- p.1 / Chapter 1.2 --- The Solution --- p.2 / Chapter 1.3 --- Goal of the Present Work --- p.2 / Chapter Chapter 2 --- Background and Methodology --- p.3 / Chapter 2.1 --- Hypertension Situation and Problems Around the World --- p.3 / Chapter 2.1.1 --- Blood Pressure Variability (BPV) --- p.4 / Chapter 2.2 --- Blood Pressure Measuring Methods --- p.5 / Chapter 2.2.1 --- Traditional Blood Pressure Meters --- p.6 / Chapter 2.2.2 --- Limitation of Commercial Blood Pressure Meters --- p.7 / Chapter 2.2.3 --- Pulse-Transit-Time (PTT) Based Blood Pressure Measuring Watch --- p.7 / Chapter 2.3 --- Wearable Body Sensors Network / System --- p.8 / Chapter 2.4 --- Current Status of e-Textile Garment --- p.9 / Chapter 2.4.1 --- Blood Pressure Measurement in e-Textile Garment --- p.13 / Chapter 2.5 --- Wearable Intelligent Sensors and System for e-Health (WISSH) --- p.15 / Chapter 2.5.1 --- "Monitoring, Connection and Display" --- p.15 / Chapter 2.5.2 --- Treatment --- p.16 / Chapter 2.5.3 --- Alarming --- p.17 / Chapter Chapter 3 --- "A h-Shirt to Non-invasive, Continuous Monitoring of Arterial Blood Pressure" --- p.18 / Chapter 3.1 --- Design and Inner Structure of h-Shirt --- p.18 / Chapter 3.1.1 --- Choose of e-Textile Material --- p.21 / Chapter 3.1.2 --- Design of ECG Circuit --- p.23 / Chapter 3.1.3 --- Design of PPG Circuit --- p.26 / Chapter 3.2 --- Blood Pressure Estimation Using Pulse-Transit-Time Algorithm --- p.28 / Chapter 3.2.1 --- Principal --- p.28 / Chapter 3.2.2 --- Equations --- p.29 / Chapter 3.2.3 --- Calibration --- p.29 / Chapter 3.3 --- Performance Tests on h-Shirt --- p.30 / Chapter 3.3.1 --- Test I: BP Measurement Accuracy --- p.30 / Chapter 3.3.2 --- Test I: Procedure and Protocol --- p.30 / Chapter 3.3.3 --- Test I-Results --- p.31 / Chapter 3.3.4 --- Test II: Continuality BP Estimation Performance --- p.31 / Chapter 3.3.5 --- Test II - Experiment Procedure and Protocol --- p.32 / Chapter 3.3.6 --- Test II - Experiment Result --- p.33 / Chapter 3.3.7 --- Test II 一 Discussion --- p.43 / Chapter 3.4 --- Follow-up Tests on ECG Circuit --- p.47 / Chapter 3.4.1 --- Problems --- p.47 / Chapter 3.4.2 --- Assumptions --- p.48 / Chapter 3.4.3 --- Experiment Protocol and Setup --- p.48 / Chapter 3.4.4 --- Experiment Results --- p.53 / Chapter 3.4.5 --- Discussion --- p.56 / Chapter Chapter 4: --- Hybrid Body Sensor Network in h-Shirt --- p.59 / Chapter 4.1 --- A Hybrid Body Sensor Network --- p.59 / Chapter 4.2 --- Biological Channel Used in h-Shirt --- p.60 / Chapter 4.3 --- Tests of Bio-channel Performance --- p.62 / Chapter 4.3.1 --- Experiment Protocol --- p.62 / Chapter 4.3.2 --- Results --- p.62 / Chapter 4.4 --- Discussion and Conclusion --- p.63 / Chapter Chapter 5: --- Conclusion and Suggestions for Future Works --- p.66 / Chapter 5.1 --- Conclusion --- p.66 / Chapter 5.1.1 --- Structure of h-Shirt --- p.66 / Chapter 5.1.2 --- Blood Pressure Estimating Ability of h-Shirt --- p.67 / Chapter 5.1.3 --- Tests and Amendments on h-Shirt ECG Circuit --- p.67 / Chapter 5.1.4 --- Hybrid Body Sensor Network in h-Shirt --- p.67 / Chapter 5.2 --- Suggestions for Future Work --- p.68 / Chapter 5.2.1 --- Further Development of Bio-channel Biological Model --- p.68 / Chapter 5.2.2 --- Positioning and Motion Sensing with h-Shirt --- p.69 / Chapter 5.2.3 --- Implementation of Updated Advance Technology into h-Shirt --- p.69 / Appendix: Non-invasive BP Measuring Device - Finometer --- p.71 / Reference: --- p.77